Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
binds to cyclophilins.
complex blocks the differentiation and activation of T cells by inhibiting calcineurin >> prevents productions of IL-2 and its receptor suppresses organ rejection; AI diseases |
Cyclosporine
SE: viral infections, lymphomas, nephrotoxic (prevent w/ mannitol) |
|
binds to FK-binding protein, inhibiting secretion of IL-2 and other cytokines
used in organ transplant recipients for immunosuppression |
Tacrolimus (FK506)
SE: nephrotoxicity |
|
binds to mTOR. inhibits T-cell proliferation in response to IL-2
post kidney transplantation in combination with cyclosporine and corticosteroids |
Sirolimus (Rapamycin)
SE: hyperlipidemia thrombocytopenia, leukopenia |
|
monoclonal antibody with high affinity for the IL-2 receptor on activated T cells
|
Daclizumab
|
|
Antimetabolite precursor of 6-mercaptopurine that interferes with the metabolism and synthesis of nucleic acids. Toxic to proliferating lymphocytes
kidney transplantation, AI disorders (glomerulonephritis and hemolytic anemia) |
Azathioprine
|
|
monoclonal antibody that binds to CD3 (epsilon chain) on the surface of T cells.
Blocks cellular interatction with CD3 protein responsible for T-cell signal transduction kidney transplantation |
Muromonab-CD3 (OKT3)
SE: cytokine release syndrome, hypersensitivity reaction |
|
erythropoeietin (epoetin)
clinical use? |
anemias (especially in renal failure)
|
|
Aldesleukin
(IL-2) clinical use? |
Renal cell carcinoma
metastatic melanoma |
|
what is the equation to find the half-life of a drug?
|
t1/2 = (0.7 x Vd) / (CL)
|
|
a drug infused at a constant rate takes _____ half-lives to reach steady state.
|
4-5 half-lives
|
|
phenytoin, ethanol, aspirin?
|
all follow zero-order elimination
|
|
phenobarbital, methotrexate, aspirin
treat this type of overdose with? |
weak acids (trapped in basic environment)
tx: bicarbonate |
|
amphetamines represent what type of pH?
treat this type of overdose with? |
weak bases (trapped in acidic environment)
tx: ammonium chloride |
|
reduction, oxidation, hydrolysis...
where do these occur (under what system)? what do they often yield as product? |
Phase I metabolism
P-450 yields slightly polar, water-soluble metabolites (often still active) |
|
acetylation, glucuronidation, sulfation
where do these occur (under what system)? what do they often yield as product? |
Phase II
conjugation yields very polar, inactive metabolites (renally excreted) |
|
geriatric patients lose which phase of metabolism first?
|
Phase I
|
|
1st pass metabolism is via ____ (oral) and is relative to the bioavailability in systemic circulation
therefore, these types of drug routes can bypass this step for quicker distribution |
liver
subL subQT suppositories (rectal) IV |
|
metabolizes steroids, alcohol, toxins, etc; can also activate inactive pro-carcinogens
|
cytochrome P450 monooxygenase
|
|
glutathione-S-transferase
|
detoxification
converts toxics >>> inactive metabolites |
|
botulinum toxin prevents release of neurotransmitter at all _______ terminals
|
cholinergic
|
|
Nicotinic ACh receptors are ligand-gated ___ channels
|
Na+/K+ channels
|
|
Muscarinic ACh receptors are _________ receptors that act through second messengers
|
G-protein-coupled receptors
|
|
(Drug) inhibits conversion of Choline >> Acetyl-CoA+Choline
|
Hemicholinium
|
|
(drug) inhibits ChAT >> ACh
|
Vesamicol
|
|
(drug) inhibits conversion tyrosine >> DOPA
|
Metyrosine
|
|
(drug) inhibits conversion Dopamine >> NE
|
Reserpine
|
|
(drug) inhibits release of NE in presynaptic terminal
|
Guanethidine
|
|
(drug) activates NE release from presynaptic terminal
|
Amaphetamine
|
|
(drug) inhibit NE reuptake
|
Cocaine, TCAs, amphetamine
|
|
Release of NE from a sympathetic nerve ending is modulated by NE itself, acting on presynaptic ___ autoreceptors, and by ACh, _________, and other substance
|
a2; angiotensin II
|
|
bethanechol
carbachol pilocarpine methacholine |
direct ACh agonists
|
|
neostigmine
pyridostigmine edrophonium physostigmine edrophonium physostigmine echothiophate |
indirect ACh antagonists
(anticholinesterases) |
|
cholinomimetic agents lead to COPD, __, and _____ in some susceptible patients
|
asthma, peptic ulcers
|
|
farmer with diarrhea, urination, miosis, bronchospasm, bradycardia, lacrimation, sweating, salivation
what is the antidote? |
cholinesterase inhibitor poisoning
often due to organophosphates, such as parathion that irreversibly inhibit AchE; found in insecticides Antidote -- atropine + pralidoxime (regenerates active AchE) |
|
atropine, homatropine, tropicamide
clinical use? |
produce mydriasis and cycloplegia (eye)
|
|
benztropine
clinical use? |
Parkinson's disease (CNS)
|
|
scopalamine
|
motion sickness (CNS)
|
|
Ipratoprium
|
Asthma, COPD (respiratory)
|
|
Oxybutynin,
glycopyrrolate |
reduce urgency in mild cystitis and reduce bladder spasms (Genitourinary)
|
|
Methscopolmaine,
pirenzepine, propantheline |
peptic ulcer treatment (GI)
|
|
after administration of this drug, SEs include fever, dry mouth, dry flushed skin, cycloplegia, constipation, disorientation
|
Atropine
acute angle-closure glaucoma (elderly) urinary retention in men with prostatic hyperplasia hyperthermia in infants |
|
ganglionic blocker
prevent vagal reflex responses to changes in blood pressure (prevents reflex bradycardia caused by NE |
Nicotinic antagonist
SEs: severe orthostatic hypotension, blurred vision, constipation, sexual dysfunction |
|
atropine
TCAs (amitriptyline) HI receptor antagonists (diphenihydramine) neuroleptics antiparkinsonian drugs |
all lead to antimuscarinic effects
|
|
Epinephrine
|
anaphylaxis, glaucoma (open angle),
asthma hypotension |
|
NE
|
hypotension (but decrease in renal perfusion)
|
|
Isoproterenol
|
AV block (rare)
|
|
Dopamine
|
shock (increased renal perfusion)
heart failure |
|
Dobutamine
|
heart failure,
cardiac stress testing |
|
Phenylephrine
|
pupillary dilation,
vasoconstriction, nasal decongestion |
|
Metaproterenol,
albuterol, salmeterol, terbutaline |
metaproterenol + albuterol = acute asthma
salmeterol = long-term tx terbutaline = reduce premature uterine contractions |
|
ritodrine
|
reduces premature uterine contractions
|
|
amphetamine
|
narcolepsy, obesity, ADD
(releases stored catecholamines; indirect sympathomimetics) |
|
ephedrine
|
nasal decongestion,
urinary incontinence, hypotension (releases stored catecholamines; indirect sympathomimetics) |
|
cocaine
|
causes vasoconstriction and local anesthesia
(uptake inhibitor) |
|
clonidine,
a-methyldopa |
hypertension, especially with renal disease (no decrease in blood flow to kidney)
|
|
phenoxybenzamine (irrev)
phentolamine (reversible) |
nonselective a-blockers
pheochromocytoma NE extravasation/vasoconstriction/vein blanching (within 12 hr) SE: orthostatic hypotension, reflex tachycardia |
|
prazosin, terazosin, doxazosin
|
a1 selective a-blocker
hypertension, urinary retention in BPH SE: 1st dose orthostatic hypotension, dizziness, HA |
|
mirtazapine
|
a2 selective a-blocker
depression SE: sedation, increased serum cholesterol, increased appetite |
|
increased vascular smooth muscle contraction
increased pupillary dilator muscle contraction (mydriasis) increased intestinal and bladder sphincter muscle contraction |
a1 receptor
(Epi, NE, Pheylephrine, Methoxamine) |
|
decreased sympathetic outflow
decreased insulin release |
a2 receptor
|
|
increased HR
increased contractility increased renin release increased lipolysis |
b1 receptor
(Epi, DA, dobutamine, isoproterenol) |
|
vasodilation
bronchodilation increased HR increased contractility increased lipolysis increased insulin release decreased uterine tone |
b2 receptor
(isoproterenol, terbutanine, ritodrine) |
|
(receptor)
CNS, enteric nervous system |
M1 receptor
|
|
(receptor)
decreased heart rate and contractility of atria |
M2 receptor
|
|
(receptor)
increased exocrine gland secretions increased gut peristalsis increased bladder contraction bronchoconstriction increased pupillary sphincter muscle contraction (miosis) ciliary muscle contraction (accommodation) |
M3 receptor
|
|
(receptor)
relaxes renal vascular smooth muscle |
D1 receptor
|
|
(receptor)
modulates transmitter release, especially in brain |
D2 receptor
|
|
(receptor)
increased nasal and bronchial mucus production, contraction of bronchioles, pruritis, and pain |
H1 receptor
|
|
(receptor)
increased gastric acid secretion |
H2 receptor
|
|
(receptor)
increased vascular smooth muscle contraction |
V1 receptor
|
|
(receptor)
increased H2O permeability and reabsorption in the collecting tubules of the kidney |
V2 receptor
|
|
class of drugs used to treat:
hypertension angina pectoris MI SVT CHR glaucoma |
beta-blockers
|
|
propranolol, timolol, nadolol, pindolol
|
nonselective antagonists (b1=b2)
|
|
betaxolol, esmolol (short acting), atenolol, metoprolol
|
b1-selective antagonists
|
|
carvedilol, labetalol
|
nonselective a- and b-antagonists
|
|
pindolol, acebutolol
|
partial b-agonists
|
|
quinidine
barbiturates St. John's wort phenytoin |
p-450 inducers
|
|
griseofulvin
carbamazepine alcohol (chronic) phenobarbitol |
p-450 inducers
|
|
HIV protease inhibitors
ketoconazole erythromycin grapefruit juice |
p-450 inhibitors
|
|
acute alcohol use
sulfonamides isoniazid ritonavir |
p-450 inhibitors
|
|
cimetidine
ciprofloxacin Azole antifungals |
p-450 inhibitors
|
|
-ane
|
inhalational gneeral anesthetic
(halothane) |
|
-azine
|
phenothiazine (neuroleptic, antiemetic)
chlorpromazine |
|
-cycline
|
antibiotic, protein synthesis inhibitor
|
|
-etine
|
SSRI
(fluoxetine) |
|
-ipramine
|
TCA
(imipramine) |
|
-navir
|
protease inhibitor
(saquinavir) |
|
-phylline
|
methylxanthine
(theophylline) |
|
-triptan
|
5-HT1B/1D agonists (migraine)
Sumatriptan |
|
-triptyline
|
TCA
(Amitriptyline) |